Q3 2026 13F filing
Updated 6 days ago173 disclosed positions worth $4.8B
Full holdings
Every line item disclosed in Q3 2026
| # | Stock | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|---|
| 1 | A AMGEN INC | $350.5M | 831.6K | 7.27% | — |
| 2 | G GILEAD SCIENCES INC | $312M | 2.09M | 6.47% | — |
| 3 | V VERTEX PHARMACEUTICALS INC | $291.4M | 557.4K | 6.05% | — |
| 4 | A ARGENX SE | $277.9M | 289.9K | 5.77% | — |
| 5 | R REGENERON PHARMACEUTICALS | $211.9M | 279.4K | 4.40% | — |
| 6 | R REVOLUTION MEDICINES INC | $201.4M | 981.0K | 4.18% | — |
| 7 | I INSMED INC | $167.4M | 1.47M | 3.47% | — |
| 8 | V VIRIDIAN THERAPEUTICS INC | $146.3M | 7.11M | 3.04% | — |
| 9 | O ORUKA THERAPEUTICS INC | $136.3M | 1.64M | 2.83% | — |
| 10 | S SCHOLAR ROCK HLDG CORP | $134.7M | 2.79M | 2.79% | — |
| 11 | B BIOGEN INC | $134.4M | 595.0K | 2.79% | — |
| 12 | P VAXCYTE INC | $132M | 2.32M | 2.74% | — |
| 13 | R RELAY THERAPEUTICS INC | $111.6M | 6.18M | 2.32% | — |
| 14 | A ABBOTT LABORATORIES | $103.6M | 1.05M | 2.15% | — |
| 15 | I INTUITIVE SURGICAL INC | $100.8M | 248.0K | 2.09% | — |
| 16 | U UNITED THERAPEUTICS CORP DEL | $98.8M | 182.3K | 2.05% | — |
| 17 | M MEDTRONIC PLC | $90M | 1.04M | 1.87% | — |
| 18 | B BRIDGEBIO PHARMA INC | $77M | 1.17M | 1.60% | — |
| 19 | I IMMUNOCORE HLDGS PLC | $68.6M | 2.26M | 1.42% | — |
| 20 | E ENLIVEN THERAPEUTICS INC | $67.3M | 1.47M | 1.40% | — |
| 21 | D DEXCOM INC | $64M | 741.9K | 1.33% | — |
| 22 | J JADE BIOSCIENCES INC | $60.3M | 4.29M | 1.25% | — |
| 23 | I INCYTE CORP | $59.5M | 489.9K | 1.23% | — |
| 24 | A ALNYLAM PHARMACEUTICALS INC | $59.2M | 240.0K | 1.23% | — |
| 25 | S STRYKER CORPORATION | $51M | 185.4K | 1.06% | — |
| 26 | E EDWARDS LIFESCIENCES CORP | $50.7M | 587.7K | 1.05% | — |
| 27 | A AXSOME THERAPEUTICS INC. | $44.3M | 240.0K | 0.92% | — |
| 28 | T THERMO FISHER SCIENTIFIC INC | $43.7M | 64.8K | 0.91% | — |
| 29 | K KODIAK SCIENCES INC | $43.6M | 460.4K | 0.91% | — |
| 30 | ? N/A DAMORA THERAPEUTICS INC | $40.8M | 1.92M | 0.85% | — |
| 31 | A AVALYN PHARMACEUTICALS INC | $38.5M | 1.35M | 0.80% | — |
| 32 | B BECTON DICKINSON & CO | $37M | 206.8K | 0.77% | — |
| 33 | I DISC MEDICINE INC | $36.7M | 560.0K | 0.76% | — |
| 34 | B BOSTON SCIENTIFIC CORP | $36.1M | 827.7K | 0.75% | — |
| 35 | U UNITEDHEALTH GROUP INC | $35.6M | 97.1K | 0.74% | — |
| 36 | S SUMMIT THERAPEUTICS INC | $35.5M | 2.10M | 0.74% | — |
| 37 | C CG ONCOLOGY INC | $35M | 493.6K | 0.73% | — |
| 38 | S SPYRE THERAPEUTICS INC | $33.2M | 373.1K | 0.69% | — |
| 39 | I IDEXX LABS INC | $32.1M | 61.5K | 0.67% | — |
| 40 | L ELI LILLY & CO | $31.8M | 27.5K | 0.66% | — |
| 41 | R RESMED INC | $31.7M | 143.5K | 0.66% | — |
| 42 | A ALTO NEUROSCIENCE INC | $29.7M | 1.16M | 0.62% | — |
| 43 | L LB PHARMACEUTICALS INC | $27.5M | 715.5K | 0.57% | — |
| 44 | T TANGO THERAPEUTICS INC | $27.4M | 1.10M | 0.57% | — |
| 45 | K KRYSTAL BIOTECH INC | $25.3M | 76.0K | 0.52% | — |
| 46 | E EUPRAXIA PHARMACEUTICALS INC | $23.6M | 2.60M | 0.49% | — |
| 47 | J JOHNSON & JOHNSON | $22.7M | 85.8K | 0.47% | — |
| 48 | G GE HEALTHCARE TECHNOLOGIES I | $22.7M | 347.2K | 0.47% | — |
| 49 | Y YARROW BIOSCIENCE INC | $22.5M | 1.00M | 0.47% | — |
| 50 | S SEAPORT THERAPEUTICS INC | $22.2M | 1.10M | 0.46% | — |